CHP investigates confirmed Mpox case
************************************
The case involves a 59-year-old male patient with chronic disease. He had developed body rash since April 25 and visited the Yau Ma Tei Male Social Hygiene Clinic of the DH on April 27. The CHP's Public Health Laboratory Services Branch confirmed that his samples tested positive for the virus yesterday evening (April 28). He was arranged to be admitted to Princess Margaret Hospital and is now in stable condition.
An initial investigation revealed that he had high risk exposure during the incubation period. According to the patient, he has travelled to the Guangdong Province for multiple times from April 2 to 19. No epidemiological linkages between this case and other confirmed cases recorded in Hong Kong earlier are found so far. The CHP's epidemiological investigations of the case are ongoing, including contact tracing and infection source investigation.
The CHP has reported the case to the World Health Organization and the relevant authority of the Mainland. Meanwhile, the CHP urges the public, especially those subject to high risks of exposure, to take precautions and avoid close physical contact with persons or animals suspected of infection. They should seek medical attention as soon as possible if they experience relevant symptoms, including rash, fever, chills, swollen lymph nodes, exhaustion, muscle pain, and severe headaches.
The CHP reminded members of the public that Mpox is not transmitted through respiratory droplets or aerosols in general and transmission would not occur through social contact. Proper personal and hand hygiene can help prevent getting infected via contact.
The Government has activated the Alert level of the preparedness and response plan for the disease in September last year, reflecting a low immediate health impact on the local population. The Government will continue to assess the risk in view of the latest scientific evidence and situation, and implement corresponding control measures.
The Mpox vaccination programme for high-risk groups commenced on October 5 last year. Under the programme, the following high-risk target groups can receive Mpox vaccination on a voluntary basis:
- Individuals with high risk sexual practices, e.g. having multiple sexual partners, sex workers, having a history of sexually transmitted infection within the past 12 months;
- Healthcare workers responsible for caring of patients with confirmed Mpox;
- Laboratory personnel working with zoonotic pox viruses; and
- Animal care personnel with high risk of exposure in case of Mpox occurrence in animals in Hong Kong.
Currently, high-risk target groups can receive Mpox walk-in vaccination at any one of the DH's six Social Hygiene Service Clinics (SocHS) (namely Wan Chai Male SocHS, Wan Chai Female SocHS, Yau Ma Tei Male SocHS, Yung Fung Shee SocHS, Fanling SocHS and Tuen Mun SocHS). Further information of the clinics including their locations is available at www.dh.gov.hk/english/tele/tele_chc/tele_chc_shcf.html and www.dh.gov.hk/english/tele/tele_chc/tele_chc_shcm.html.
Meanwhile, the DH's Integrated Treatment Centre in Kowloon Bay, and the Hospital Authority's Special Medical Clinics at Queen Elizabeth Hospital and Princess Margaret Hospital will continue to provide Mpox vaccination service for their clients.
ýÿýÿýÿFor more details, please visit the CHP's page on Mpox.
Ends/Saturday, April 29, 2023
Issued at HKT 16:30
Issued at HKT 16:30
NNNN